Dr. Broeders' research focuses on the evaluation of the long-term benefits and harms of screening for breast cancer. In particular, she aims to study whether moving from the current 'one-size-fits-all' screening policies to more individualised screening approaches can help optimise the efficacy of breast cancer screening, by maximising its life-sparing effect and minimising side effects. She has a special interest in observational research designs that can be used in the evaluation of cancer screening. In addition, she conducts studies to evaluate the implementation of technological developments in the breast screening programme, such as the effect of the transition to digital mammography, the effects of image processing and pain experience during breast compression.
Dr. Broeders obtained her MSc in Biomedical Sciences (major in epidemiology) at the Radboud University Nijmegen (RUN). In 2004, she completed her thesis on the long-term evaluation of the Nijmegen demonstration programme for breast cancer screening at the department of Epidemiology of the RUN. Currently she is appointed associate professor at the department for Health Evidence, Radboud University Medical Centre. She further works as scientific supervisor at the Dutch Reference Centre for Screening in Nijmegen which aims at the safeguard and constant improvement of the quality of the breast cancer screening programme. At a European level, dr. Broeders contributes, as editor and author, to the European Guidelines for Quality Assurance for Breast Screening and Diagnosis.